Do Glucosamine and Chondroitin Work for Knee Pain? Big Trials vs Small Ones

Large trials found little or no benefit for osteoarthritis pain, smaller and industry-funded trials found more, and medical guidelines disagree.

Key takeaways

From 6 sources
  • In the 24-week GAIT trial of 1,583 people with knee osteoarthritis, glucosamine, chondroitin or both were not significantly better than placebo for pain overall1.
  • A network meta-analysis of 10 large trials (3,803 patients) found pain differences below the threshold patients notice, and smaller effects in industry-independent trials2.
  • A Cochrane review found a small chondroitin benefit: 53 of 100 versus 47 of 100 on placebo reached a 20% drop in knee pain3.
  • The American College of Rheumatology and an international osteoarthritis society advise against both for knee osteoarthritis, while a US orthopaedic guideline lists them as possibly helpful6.
  • Raised INR and bleeding have been reported when glucosamine was added to warfarin56.

What this article covers

2 evidence profiles

The evidence, graded

Pulled from the trial tables in our evidence profiles. Grades follow our evidence-grading policy.

Graded findings

4 rows
  1. No effectKnee osteoarthritis pain (20% reduction)No effect Glucosamine and chondroitin, alone or together, were not significantly better than placebo for knee pain overall.Glucosamine · RCT · n=1,583 · 2006 · PMID 16495392
  2. No effectJoint pain and joint-space narrowingNo effect Compared with placebo, effects on pain and joint-space narrowing were below clinically relevant thresholds; industry-independent trials showed smaller effects.Glucosamine · Meta-analysis · n=3,803 · 2010 · PMID 20847017
  3. Grade BOsteoarthritis pain (20% reduction, WOMAC)Improved 53 of 100 on chondroitin versus 47 of 100 on placebo reached a 20% drop in knee pain (high-quality evidence); across all 43 trials pain scores were 10 points lower in short trials, but with low-quality, heterogeneous evidence.Chondroitin · Systematic review · n=1,253 · 2015 · PMID 25629804
  4. Grade COsteoarthritis pain (knee or hip)Mixed Heterogeneity was very high (I² 92%); small and lower-quality trials showed larger benefits, and the 3 large intention-to-treat trials showed essentially no effect.Chondroitin · Meta-analysis · n=3,846 · 2007 · PMID 17438317

The GAIT trial

GAIT randomly assigned 1,583 people with knee osteoarthritis (mean age 59) to 1,500 mg glucosamine, 1,200 mg chondroitin, both, the painkiller celecoxib or placebo for 24 weeks1. The goal was a 20% drop in knee pain1.

Placebo reached that goal in 60.1% of people1. Response was 3.9 percentage points higher with glucosamine, 5.3 with chondroitin and 6.5 with the combination, none statistically significant, while celecoxib was 10.0 points higher and significant1.

In an exploratory subgroup with moderate-to-severe pain, 79.2% responded on the combination versus 54.3% on placebo1. The authors labelled this subgroup analysis exploratory1.

What the pooled analyses found

A 2010 network meta-analysis limited itself to large trials with more than 200 patients each: 10 trials and 3,803 people with knee or hip osteoarthritis2. On a 10 cm pain scale, differences versus placebo were 0.4 cm for glucosamine, 0.3 cm for chondroitin and 0.5 cm for the combination, all short of the 0.9 cm the authors set as clinically meaningful2.

A 2007 meta-analysis of 20 chondroitin trials found very high heterogeneity (I² 92%)4. Small trials and lower-quality trials showed larger benefits, while the 3 large trials that analysed every randomized patient showed essentially no effect4.

The 2015 Cochrane chondroitin review was more positive3. In 2 low-risk-of-bias trials with 1,253 people, 53 of 100 on chondroitin versus 47 of 100 on placebo reached a 20% pain drop, rated high-quality evidence3. Across all 43 trials, most of low quality, the benefit became uncertain when the analysis was limited to large trials or trials without pharmaceutical funding3.

Funding and product type matter

Industry-independent trials showed smaller effects than commercially funded ones in the 2010 analysis2. NCCIH notes that studies of a prescription glucosamine sulfate product tended to be more favourable, but most were older, had a high risk of bias and were funded by the drug company6.

Guidelines split along these lines6. The American College of Rheumatology and the Osteoarthritis Research Society International advise against glucosamine and chondroitin for knee osteoarthritis, the American Academy of Orthopaedic Surgeons lists them as possibly helpful for mild-to-moderate cases while cautioning that the evidence is inconsistent, and a European society backs only prescription-grade products6.

Safety and who should be careful

No major safety problems appeared in large studies, and adverse events in GAIT were mild and evenly spread across groups61. The cautions below come from NCCIH and FDA safety reports:

  • People on warfarin: a review by FDA staff found 20 MedWatch reports of altered clotting, such as a higher INR or more bleeding or bruising, when glucosamine or glucosamine-chondroitin was combined with warfarin, and NCCIH links both supplements to a higher bleeding risk with warfarin56.
  • People with diabetes: glucosamine may raise blood sugar in some people6.
  • Pregnancy and breastfeeding: little is known about safety6.

Quick answers

Common questions

3 answers
What doses did GAIT use?

GAIT used 1,500 mg of glucosamine and 1,200 mg of chondroitin a day for 24 weeks1.

Is chondroitin better than glucosamine?

The Cochrane review found a small chondroitin benefit in its best trials, but the large-trial analysis found neither reached a clinically meaningful difference32.

Do they rebuild cartilage?

Neither has been shown to rebuild cartilage. In the 2010 large-trial analysis, differences in joint-space narrowing were minute and overlapped zero2. The Cochrane review found slightly less joint-space loss with chondroitin in 2 low-risk-of-bias trials, a relative difference of 4.7%3.

Keep reading

Full evidence profiles

Every graded study, studied doses, interactions and safety

Related articles

4 articles

Browse the full Supplement & Nutrient Encyclopedia or all supplement articles.

Where to buy Glucosamine

Products from brands we partner with that contain Glucosamine. Check the amount per serving against the doses studied, and the label for other ingredients.

Glucosamine products from partner brands

1 product
  • HerbsProNOW Foods Glucosamine, 1000 mg, 60 Caps

    2 capsules: 2,000 mg glucosamine HCl plus 100 mg licorice root; no chondroitin

    $10.61one-timeChecked Oct 15, 2026

Listing a product is not a claim that it works; check the amount per serving against the doses studied, and the label for other ingredients.Prices and labels are from each brand’s own site on the date shown; confirm before you buy.

Partner links may earn us a commission. How partner links work

Glucosamine and other dietary supplements are not intended to diagnose, treat, cure or prevent any disease, and these statements have not been evaluated by the FDA. Talk to your clinician or pharmacist before starting a supplement, especially if you take prescription medicines. Product links on this page are paid partner links.

Educational only. Not medical advice. Some links earn us a commission: kymatahealth.com/affiliate-disclosure.